Caricamento...
Ipilimumab in prostate cancer
INTRODUCTION: Immune checkpoint inhibitors, such as ipilimumab, are a new class of immunotherapeutic agents that have shown significant efficacy in melanoma. A number of ongoing clinical trials are investigating the role of ipilimumab in prostate cancer, either alone or in combination with immunomod...
Salvato in:
| Pubblicato in: | Expert Opin Biol Ther |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628899/ https://ncbi.nlm.nih.gov/pubmed/23265575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2012.754421 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|